Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Mulloy

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|May 5, 2010
Peripheral T cell lymphoma: new model + new insightJames C Mulloy
EMBO Molecular Medicine|November 5, 2013
A new inducible model for t(8;21) AMLJames C Mulloy
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transductionMark Wunderlich, James C Mulloy
International Journal of Hematology|May 4, 2011
Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospectsSusumu Goyama, James C Mulloy
Cell Stem Cell|January 8, 2013
Making healthy stem cells: the new role of TPOSusumu Goyama, James C Mulloy
Blood|October 30, 2016
MISTRG extends PDX modeling to favorable AMLsMark Wunderlich, James C Mulloy
Cancer Cell|October 19, 2013
NF-κB: a coordinator for epigenetic regulation by MLLSusumu Goyama, James C Mulloy
Journal of Cellular Biochemistry|March 2, 2011
The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesisFu-Sheng Chou, James C Mulloy
Advances in Experimental Medicine and Biology|March 17, 2017
RUNX1-ETO LeukemiaShan Lin, James C Mulloy, Susumu Goyama
Blood|March 13, 2015
Xenograft models for normal and malignant stem cellsSusumu Goyama, Mark Wunderlich, James C Mulloy
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|May 5, 2010
Peripheral T cell lymphoma: new model + new insightJames C Mulloy
EMBO Molecular Medicine|November 5, 2013
A new inducible model for t(8;21) AMLJames C Mulloy
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transductionMark Wunderlich, James C Mulloy
International Journal of Hematology|May 4, 2011
Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospectsSusumu Goyama, James C Mulloy
Cell Stem Cell|January 8, 2013
Making healthy stem cells: the new role of TPOSusumu Goyama, James C Mulloy
Blood|October 30, 2016
MISTRG extends PDX modeling to favorable AMLsMark Wunderlich, James C Mulloy
Cancer Cell|October 19, 2013
NF-κB: a coordinator for epigenetic regulation by MLLSusumu Goyama, James C Mulloy
Journal of Cellular Biochemistry|March 2, 2011
The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesisFu-Sheng Chou, James C Mulloy
Advances in Experimental Medicine and Biology|March 17, 2017
RUNX1-ETO LeukemiaShan Lin, James C Mulloy, Susumu Goyama
Blood|March 13, 2015
Xenograft models for normal and malignant stem cellsSusumu Goyama, Mark Wunderlich, James C Mulloy
Pageof 10